Jinwon Life Sciences has ranked among the top searched stocks for 13 days in the past month.

As of 2:35 PM on the 16th, Jinwon Life Sciences is trading at 8,700 KRW, down 6.75% from the previous day. This represents a 10.22% decline compared to June 30. Jinwon Life Sciences is known as a company specializing in the development of gene therapies and gene vaccines.

Today, foreigners have sold a net 10,000 shares of Jinwon Life Sciences, and institutions have sold a net 6,000 shares, according to provisional data. Over the past five days, individual investors have bought a net 61,731 shares, while foreigners and institutions have bought a net 171,907 shares and sold a net 230,401 shares, respectively.

On July 15, Jinwon Life Sciences was a market topic for its "upward trend following the administration of the Inovio COVID-19 vaccine candidate."



[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)
※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing